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Abstract
Whereas the pulmonary artery catheter (PAC) is still widely used in
guiding assessment and treatment of heart failure, controversy
surrounding its safety and efficacy has prompted development of
newer, less invasive techniques. For these purposes, the
transpulmonary thermodilution technique allows assessment of
preload, cardiac output, filling volumes, and metrics of contractility
without the need to pass a catheter through the right heart. In a
previous issue of Critical Care, Ritter and colleagues compare
metrics of transpulmonary thermodilution with the PAC in patients
with acute heart failure and severe sepsis. The results add to a
growing body of evidence that the PAC adds little to information
attainable by less invasive methods in many conditions, including
acute heart failure. Whether newer devices improve outcome
needs to be tested in well-controlled prospective trials.
In a previous issue of Critical Care a comparison was made
between metrics of transpulmonary thermodilution (TPT) and
the pulmonary artery catheter (PAC) in patients with acute
heart failure (AHF) and sepsis [1]. The results showed
acceptable correlation between metrics derived from the two
techniques and showed that TPT allowed identification of
heart dysfunction in both heart failure and sepsis. This study,
while small and retrospective, adds to mounting evidence that
routine use of the PAC is probably no longer warranted in
AHF and many other conditions. It appears that a grand
chapter in the intensive care medicine story may be coming
to an end.
The PAC first came into widespread use after its introduction
by Swan and Ganz in 1970 [2]. Their balloon-tipped, flow-
directed catheter allowed clinicians for the first time to assess
advanced parameters of hemodynamics and gas exchange at
the bedside – and it was an overnight success. In fact, the
catheter was so enthusiastically adopted that it helped define
the modern intensive care unit for the coming decades. But
the device was introduced without clinical trials establishing
benefit, and in the ensuing years much debate as regards its
safety and efficacy has occurred. Opponents of the device
state that it has never been shown to improve major clinical
outcomes [3-10], and in fact might increase mortality and
morbidity [3,11]. Both the left ventricular stroke work index
(LVSWI) and cardiac power (CP), however, have been found
to be excellent prognosticators in cardiac surgery and AHF
[12], and many feel that the pulmonary artery occlusion
pressure may provide useful information on the function of the
left ventricle. As such, the PAC device is still recommended
in patients with heart failure [13].
Since the introduction of the PAC, newer technologies have
emerged that allow less invasive assessment of cardiac
function. One such device, the PiCCO™ (Pulsion Medical
Systems, Munich, Germany), uses the TPT method to assess
preload, cardiac output, filling volumes, extravascular lung
water and parameters of cardiac function. The technique
requires only central venous access and an arterial line, and
therefore may be safer than the PAC. But many TPT metrics
remain relatively untested with regards to gold standard
techniques in the assessment and treatment of heart failure.
The study by Ritter and colleagues retrospectively compared
metrics of cardiac function in patients with sepsis and AHF
as determined by the PiCCO™ and by the PAC [1]. They
compared the cardiac function index and the global ejection
fraction – PiCCO™ metrics – with the LVSWI and the CP
calculated from measurements taken by the PAC. Patients
with AHF had a lower cardiac index, a lower LVSWI, a lower
CP and a higher pulmonary artery occlusion pressure as
determined by the PAC. These same patients had a lower
cardiac function index and global ejection fraction as
determined by the PiCCO™. Reasonable correlation of the
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cardiac function index to the LVSWI and CP was observed.
Additionally, the cardiac function index allowed identification
of patients with cardiac dysfunction in both heart failure and
severe sepsis. The study was small, retrospective and
observational, limiting interpretation of the results. The
authors, however, used repeated measures over steady-state
periods in two very distinct patient populations and showed
good correlation in measurements of cardiac function over
the treatment course, which helped to compensate for some
of these limitations.
Given that there are now reliable less invasive alternatives to
the PAC that can accurately determine cardiac output,
preload status, fluid responsiveness, and the etiology of
shock, the need for routine use of the PAC in sepsis, in acute
respiratory distress syndrome, and in most surgical settings
has already been called into question [14]. It now appears in
light of this present study and others that the PAC is not
needed in the assessment of or the treatment of AHF or
sepsis-related cardiomyopathy [3,4,7].
But what devices should we be using, and in what diseases?
To effectively answer these questions, as the authors
themselves have stated, we must now demonstrate efficacy
of newer devices such as the PiCCO™ as compared with the
PAC in large prospective outcome studies. The studies
should be based on current treatment recommendations
and/or new algorithmic approaches, since it is not just the
device but also how it is used that potentially changes
outcome. But should we continue to use the PAC until we
have further proof? For the time being there appears to be
enough evidence to say that the PAC adds little to
information attainable by less invasive measures and should
probably no longer be a part of routine management for
conditions other than right heart failure, disorders causing
abnormalities of pulmonary arterial pressure, and congenital
heart disease.
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